Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury.

We examined the effects of upregulation of heme oxygenase-1 (HO-1) in steatotic rat liver models of ex vivo cold ischemia/reperfusion (I/R) injury. In the model of ischemia/isolated perfusion, treatment of genetically obese Zucker rats with the HO-1 inducer cobalt protoporphyrin (CoPP) or with adenoviral HO-1 (Ad-HO-1) significantly improved portal venous blood flow, increased bile production, and decreased hepatocyte injury. Unlike in untreated rats or those pretreated with the HO-1 inhibitor zinc protoporphyrin (ZnPP), upregulation of HO-1 by Western blots correlated with amelioration of histologic features of I/R injury. Adjunctive infusion of ZnPP abrogated the beneficial effects of Ad-HO-1 gene transfer, documenting the direct involvement of HO-1 in protection against I/R injury. Following cold ischemia/isotransplantation, HO-1 overexpression extended animal survival from 40% in untreated controls to about 80% after CoPP or Ad-HO-1 therapy. This effect correlated with preserved hepatic architecture, improved liver function, and depressed infiltration by T cells and macrophages. Hence, CoPP- or gene therapy-induced HO-1 prevented I/R injury in steatotic rat livers. These findings provide the rationale for refined new treatments that should increase the supply of usable donor livers and ultimately improve the overall success of liver transplantation.

[1]  A. Choi,et al.  Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. , 1999, The Journal of clinical investigation.

[2]  N. Parry,et al.  A RATIONALLY DESIGNED IMMUNOMODULATORY PEPTIDE UPPREGULATES EXPRESSION OF HEMEOXYGENASE-1 AND ATTENUATES CHRONIC REJECTION IN A RAT RENAL ALLOGRAFT MODEL , 1999 .

[3]  M. Maines,et al.  Overexpression of Heme Oxygenase‐1 Is Neuroprotective in a Model of Permanent Middle Cerebral Artery Occlusion in Transgenic Mice , 1999, Journal of neurochemistry.

[4]  E. Squiers,et al.  Pretreatment of small bowel isograft donors with cobalt-protoporphyrin decreases preservation injury. , 1999, Transplantation proceedings.

[5]  L. Turka,et al.  Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes , 1998, Nature Medicine.

[6]  B. Fellström,et al.  Postischemic reperfusion injury and allograft arteriosclerosis. , 1998, Transplantation proceedings.

[7]  R. Colvin,et al.  Expression of heme oxygenase-1 can determine cardiac xenograft survival , 1998, Nature Medicine.

[8]  R. Busuttil,et al.  Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. , 1998, Annals of surgery.

[9]  M. Maines,et al.  Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). , 1998, Transplant immunology.

[10]  M. Maines,et al.  Characterization and Biological Significance of Immunosuppressive Peptide D2702.75–84(E → V) Binding Protein , 1998, The Journal of Biological Chemistry.

[11]  B. Koneru,et al.  Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells. , 1998, Transplantation.

[12]  S. Tonegawa,et al.  Reduced stress defense in heme oxygenase 1-deficient cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Abraham,et al.  Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. , 1997, Biochemical pharmacology.

[14]  Karl A. Nath,et al.  Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury. , 1996, The Journal of clinical investigation.

[15]  A. Choi,et al.  Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. J. Wolff,et al.  Inhibition of nitric oxide synthase isoforms by porphyrins. , 1996, Archives of biochemistry and biophysics.

[17]  D. Stevenson,et al.  Duration of Action and Tissue Distribution of Zinc Protoporphyrin in Neonatal Rats , 1996, Pediatric Research.

[18]  S. Nakamura,et al.  Involvement of platelet‐activating factor in cytokine production and neutrophil activation after hepatic ischemia‐reperfusion , 1996, Hepatology.

[19]  M. Tempero,et al.  Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity of human lymphocytes. , 1996, Biochimica et biophysica acta.

[20]  A. Houweling,et al.  Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. , 1996, Human gene therapy.

[21]  A. Choi,et al.  Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. , 1995, American journal of respiratory cell and molecular biology.

[22]  J. Alam,et al.  Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. , 1995, Kidney international.

[23]  A. Coito,et al.  Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats. , 1995, Journal of immunology.

[24]  T. Howard,et al.  Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation , 1994, Hepatology.

[25]  R. Stocker,et al.  Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. , 1994, The Journal of biological chemistry.

[26]  K. Nath.  The functional significance of induction of heme oxygenase by oxidant stress. , 1994, The Journal of laboratory and clinical medicine.

[27]  H. Shau,et al.  Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. , 1994, Biochemical and biophysical research communications.

[28]  J. Kupiec-Weglinski,et al.  The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats. , 1994, Transplantation.

[29]  P. Howdle,et al.  Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation , 1994, Hepatology.

[30]  B. Beutler,et al.  Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Stratta,et al.  FROZEN SECTION EVALUATION OF DONOR LIVERS BEFORE TRANSPLANTATION , 1993, Transplantation.

[32]  T. Kinoshita,et al.  A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. , 1993, Biochimica et biophysica acta.

[33]  L. Toledo-Pereyra,et al.  NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY , 1993, Transplantation.

[34]  A. Boveris,et al.  Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. , 1993, The Journal of clinical investigation.

[35]  C. Newgard,et al.  Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. , 1992, The Journal of biological chemistry.

[36]  G. Vercellotti,et al.  Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. , 1992, The Journal of clinical investigation.

[37]  M. Maines.  Heme Oxygenase: Clinical Applications and Functions , 1992 .

[38]  E. Murray.  Gene Transfer and Expression Protocols , 1991 .

[39]  S. Knechtle,et al.  The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. , 1991, Transplantation.

[40]  I. Marzi,et al.  Hepatic reperfusion injury following orthotopic liver transplantation in the rat. , 1988, Transplantation.

[41]  F. Graham,et al.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. , 1988, Virology.

[42]  B. Brüne,et al.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. , 1987, Molecular pharmacology.

[43]  S. Shibahara,et al.  Cloning and expression of cDNA for rat heme oxygenase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Ignarro,et al.  Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. , 1984, The Journal of biological chemistry.

[45]  T. Olsen,et al.  Fatty changes in the liver: the relation to age, overweight and diabetes mellitus. , 1982, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[46]  R. Calne,et al.  ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT: TECHNIQUE USING CUFF FOR PORTAL VEIN ANASTOMOSIS AND BILIARY DRAINAGE , 1979, Transplantation.

[47]  Y. Niida,et al.  Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. , 1999, The Journal of clinical investigation.

[48]  M. Maines,et al.  The heme oxygenase system: a regulator of second messenger gases. , 1997, Annual review of pharmacology and toxicology.

[49]  D. Willis,et al.  Heme oxygenase: A novel target for the modulation of inflammatory response , 1996, Nature Medicine.

[50]  F. Graham,et al.  Adenovirus-based expression vectors and recombinant vaccines. , 1992, Biotechnology.